About: Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function
Creator	Guy, Jodie Hooper, Nigel Lambert, Dan Turner, Anthony Warner, Fiona
Source	Medline; PMC
abstract	Angiotensin converting enzyme-2 (ACE2) is a recently described homologue of the vasoactive peptidase, angiotensin converting enzyme (ACE). Like ACE, ACE2 is an integral (type I) membrane zinc metallopeptidase, which exists as an ectoenzyme. ACE2 is less widely distributed than ACE in the body, being expressed at highest concentrations in the heart, kidney and testis. ACE2 also differs from ACE in its substrate specificity, functioning exclusively as a carboxypeptidase rather than a peptidyl dipeptidase. A key role for ACE2 appears to be emerging in the conversion of angiotensin II to angiotensin (1–7), allowing it to act as a counter-balance to the actions of ACE. ACE2 has been localised to the endothelial and epithelial cells of the heart and kidney where it may have a role at the cell surface in hydrolysing bioactive peptides such as angiotensin II present in the circulation. A role for ACE2 in the metabolism of other biologically active peptides also needs to be considered. ACE2 also serendipitously appears to act as a receptor for the severe acute respiratory syndrome (SARS) coronavirus. Studies using ace2 (-/-) mice, and other emerging studies in vivo and in vitro, have revealed that ACE2 has important functions in cardiac regulation and diabetes. Together with its role as a SARS receptor, ACE2 is therefore likely to be an important therapeutic target in a diverse range of disease states.
has issue date	2003-01-01(xsd:dateTime)
bibo:doi	10.1007/s10989-004-2387-6
bibo:pmid	32214681
has license	no-cc
sha1sum (hex)	dc8e5b7acbe76c40ab168d2dbf39a5927bfac721
schema:url	https://doi.org/10.1007/s10989-004-2387-6
resource representing a document's title	Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function
has PubMed Central identifier	PMC7088140
has PubMed identifier	32214681
schema:publication	Lett
resource representing a document's body	covid:dc8e5b7acbe76c40ab168d2dbf39a5927bfac721#body_text
is schema:about of	named entity 'ACE2' named entity 'ACE' named entity 'heart' named entity 'circulation' named entity 'ectoenzyme' named entity 'ACE2' named entity 'hypertension' named entity 'ANGIOTENSIN CONVERTING ENZYME' named entity 'ROLES' named entity 'ACE' named entity 'USING' named entity 'CONSIDERED' named entity 'KIDNEY' named entity 'MEMBRANE' named entity 'DESCRIBED' named entity 'LIKE' named entity 'PEPTIDYL DIPEPTIDASE' named entity 'IN VITRO' named entity 'ACE2' named entity 'FUNCTIONING' named entity 'HAVE' named entity 'COUNTER' named entity 'METALLOPEPTIDASE' named entity 'MAY HAVE' named entity 'ANGIOTENSIN' named entity 'THERAPEUTIC TARGET' named entity 'ENDOTHELIAL' named entity 'RECEPTOR' named entity 'SARS' named entity 'HYDROLYSING' named entity 'CORONAVIRUS' named entity 'RANGE' named entity 'DISEASE' named entity 'FUNCTIONS' named entity 'CONCENTRATIONS' named entity 'DIVERSE' named entity 'LIKELY' named entity 'INTEGRAL' named entity 'BALANCE' named entity 'ACTIONS' named entity 'PEPTIDES' named entity 'CIRCULATION' named entity 'RECENTLY' named entity 'BODY' named entity 'HIGHEST' named entity 'IS A' named entity 'WHERE' named entity 'THE CELL' named entity 'ACT' named entity 'CARDIAC' named entity 'ROLE' named entity 'TESTIS' named entity 'KEY' named entity 'EXPRESSED' named entity 'REVEALED' named entity 'CELL SURFACE' named entity 'REGULATION' named entity 'EPITHELIAL CELLS' named entity 'PEPTIDASE' named entity 'ITS' named entity 'POSSIBLE' named entity 'HYPERTENSION' named entity 'ALLOWING' named entity 'NEEDS' named entity 'VASOACTIVE' named entity 'IMPORTANT' named entity 'ZINC' named entity 'DISTRIBUTED' named entity 'SEVERE ACUTE RESPIRATORY SYNDROME' named entity 'ITS' named entity 'PRESENT' named entity 'ACTIVE' named entity 'HOMOLOGUE' named entity 'STUDIES' named entity 'LOCALISED' named entity 'STATES' named entity 'BIOLOGICALLY'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software